Four UC Berkeley faculty members, whose technological innovations promise to deliver solutions to some of the world’s most pressing problems, have been awarded the Bakar Fellows Program 2022 Bakar Prize.

Up to 20 percent of UTIs are caused by a particularly resistant microbe known as ESBL-producing bacteria. These infections do not respond to the standard antibiotic treatment. With support as a 2019-2020 Bakar FellowNiren Murthy, professor of bioengineering, and colleagues have developed a 30-minute, low-tech test, called DETECT, to identify ESBL-producing bacteria on a patient’s first visit to the doctor.

Thanks to a rapid funding program thrown together by wealthy entrepreneurs barely six weeks ago, seven COVID-19 research projects at the University of California, Berkeley, are getting an infusion of cash — $2.2 million in all — that could turn up new diagnostics and potential treatments for the infection within months.

Seven University of California, Berkeley, faculty scientists with novel ideas and an entrepreneurial spirit have been named to the 2019-20 cohort of Bakar Fellows, an honor that gives the fellows the money and time to translate their laboratory breakthroughs into technologies ready for the marketplace.

A team of engineers at the UC Berkeley and the Keck Graduate Institute (KGI) of The Claremont Colleges combined CRISPR with electronic transistors made from graphene to create a new hand-held device that can detect specific genetic mutations in a matter of minutes.

The technique could help doctors prescribe the right antibiotics fast.

Scientists have used CRISPR-Cas9 gene editing to lessen some autism symptoms in mice with a form of fragile X syndrome, the most common known single-gene cause of autism spectrum disorder.